Deficiency in platelet 12-lipoxygenase exacerbates inflammation and disease severity during SARS-CoV-2 infection
Proceedings of the National Academy of Sciences · 25.03.2025 · 122 (12)
DOI: 10.1073/pnas.2420441122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 18.03.2025. Verfasst von Ana Claudia Dos S P Andrade und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious and Immune Diseases, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, QC G1V 4…. Hauptthemen laut MEDLINE: COVID-19, Blood Platelets, Arachidonate 12-Lipoxygenase, Inflammation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Government | Canadian Institutes of Health Research (CIHR).
Abstract (Originalsprache)
Platelets, known for maintaining blood balance, also participate in antimicrobial defense. Upon severeacute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, platelets become hyperactivated, releasing molecules such as cytokines, granule contents, and bioactive lipids. The key effector biolipids produced by platelets include 12-hydroxyeicosatetraenoic acid (12-HETE) and 12-hydroxyeicosatrienoic acid (12-HETrE), produced by 12-lipoxygenase (12-LOX), and prostaglandins and thromboxane, produced by cyclooxygenase-1. While prostaglandin E2 and thromboxane B2 were previously associated with lung inflammation in severe COVID-19, the role of platelet 12-LOX in SARS-CoV-2 infection remains unclear. Using mice deficient for platelets’ 12-LOX, we report that SARS-CoV-2 infection resulted in higher lung inflammation characterized by histopathological tissue analysis, increased leukocyte infiltrates, and cytokine production relative to wild-type mice. In addition, distinct platelet and lung transcriptomic changes, including alterations in NOD-like receptor (NLR) family pyrin domain-containing 1 (NLRP1) inflammasome-related gene expression, were observed. Mass spectrometry lipidomic analysis in 12-LOX-deficient-infected mice revealed significant changes in bioactive lipid content, including reduced levels of 12-HETrE that inversely correlated with disease severity. Finally, platelet 12-LOX deficiency was associated with increased morbidity and lower survival rates relative to wild type (WT) mice. Overall, this study highlights the complex interplay between 12-LOX-related lipid metabolism and inflammatory responses during SARS-CoV-2 infection. The findings provide valuable insights into potential therapeutic targets aimed at mitigating severe outcomes, emphasizing the pivotal role of platelet enzymes in the host response to viral infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious and Immune Diseases, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, QC G1V 4G2, Canada.
- Division of Reproduction, mother and youth health, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, QC G1V 4G2, Canada.
- Morphology Department, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
- Division of Endocrinology and Nephrology, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, QC G1V 4G2, Canada.
- Centre de recherche de l'Institut Universitaire de cardiologie et pneumologie de Québec, Division of pneumology, Faculty of medicine, Université Laval, Québec City, QC G1V 4G5, Canada.
- Canada Excellence Research Chair on the Microbiome-Endocannabinoidome Axis in Metabolic Health, Université Laval, Québec City, QC G1V 4G5, Canada.
ORCID-Profile: Annie Gravel, Florian Puhm, Isabelle Allaeys, Oumaima Azeggouar Wallen, Nicolas Flamand, Éric Boilard, Louis Flamand
Förderung
- Canadian Government | Canadian Institutes of Health Research (CIHR)
Zitieren
APA
Dos S P Andrade, A. C., Lacasse, E., Dubuc, I., Gudimard, L., Gravel, A., Puhm, F., Campolina-Silva, G., Queiroz-Junior, C., Allaeys, I., Prunier, J., Azeggouar Wallen, O., Dumais, É., Belleannée, C., Droit, A., Flamand, N., Boilard, É., & Flamand, L. (2025). Deficiency in platelet 12-lipoxygenase exacerbates inflammation and disease severity during SARS-CoV-2 infection. Proceedings of the National Academy of Sciences, 122(12). https://doi.org/10.1073/pnas.2420441122
Vancouver
Dos S P Andrade AC, Lacasse E, Dubuc I, Gudimard L, Gravel A, Puhm F, et al. Deficiency in platelet 12-lipoxygenase exacerbates inflammation and disease severity during SARS-CoV-2 infection. Proceedings of the National Academy of Sciences. 2025;122(12). doi:10.1073/pnas.2420441122
BibTeX
@article{DosSPAndrade2025,
author = {Dos S P Andrade, Ana Claudia and Lacasse, Emile and Dubuc, Isabelle and Gudimard, Leslie and Gravel, Annie and Puhm, Florian and Campolina-Silva, Gabriel and Queiroz-Junior, Celso and Allaeys, Isabelle and Prunier, Julien and Azeggouar Wallen, Oumaima and Dumais, Élizabeth and Belleannée, Clémence and Droit, Arnaud and Flamand, Nicolas and Boilard, Éric and Flamand, Louis},
title = {Deficiency in platelet 12-lipoxygenase exacerbates inflammation and disease severity during SARS-CoV-2 infection},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {12},
doi = {10.1073/pnas.2420441122}
}
EUVIMED